v3.19.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Current assets    
Cash $ 4,097,520 $ 8,222,119
Prepaid expenses and other current assets 257,363 238,040
Total current assets 4,354,883 8,460,159
Equipment, net 51,001 36,271
Total assets 4,405,884 8,496,430
Current liabilities    
Accounts payable 1,800,453 1,738,837
Accrued expenses and other current liabilities 540,521 1,330,746
Senior Secured Convertible Note issued December 31, 2018, at fair value - (face value principal of $4,369,000 and $7,750,00 as of September 30, 2019 and December 31, 2018, respectively) 4,471,535 7,903,000
Total liabilities 6,812,509 10,972,583
COMMITMENTS AND CONTINGENCIES (NOTE 3)
Stockholders' Deficit    
Common stock, par value $0.001; 100,000,000 shares authorized; 36,556,178 and 27,142,979 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively 36,556 27,143
Additional paid-in capital 43,251,674 32,619,282
Accumulated deficit (47,402,814) (36,992,911)
Total PAVmed Inc Stockholders'Deficit (1,886,269) (2,314,641)
Noncontrolling interest (520,356) (161,512)
Total Stockholders' Deficit (2,406,625) (2,476,153)
Total Liabilities and Stockholders' Deficit 4,405,884 8,496,430
Series B Convertible Preferred Stock [Member]    
Stockholders' Deficit    
Preferred stock, par value $0.001, 20,000,000 shares authorized $ 2,228,315 $ 2,031,845

Source